Levodopa and the risk of melanoma.
Zanetti
Roberto
R
Piedmont Cancer Registry-CPO, Turin 10123, Italy. roberto.zanetti@cpo.it
Rosso
Stefano
S
D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016022:Case-Control Studies; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use*; D008545:Melanoma / Q000139:chemically induced*; D010300:Parkinson Disease / Q000188:drug therapy* / Q000517:prevention & control; D012042:Registries; D012307:Risk Factors; D012907:Smoking
D000978:Antiparkinson Agents; D007980:Levodopa